Supplemental New Drug Application for at-home Igalmi aims to provide a self-administered option for agitation in schizophrenia and bipolar disorder.
An older man presents with acute coronary syndrome and a large atrial myxoma, complicating diagnosis and guiding decisions on revascularization and surgery.
MONTREAL and CHARLOTTE, N.C., March 16, 2026 (GLOBE NEWSWIRE)-- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...
Romano-Ward syndrome, the most common congenital long QT disorder, often causes exertion- or stimulus-triggered syncope and ...
The Medicity, Gurugram emphasize early diagnosis amid rising incidence of bradycardia: Our Bureau, Bengaluru Wednesday, April 1, 2026, 12:45 Hrs [IST] Medanta – The ...
MedPage Today on MSN
Mavacamten Poised to Expand to Pediatric Obstructive Hypertrophic Cardiomyopathy
The cardiac myosin inhibitor gets a big win in the SCOUT-HCM trial ...
Intense heat can overcome our body's ability to maintain a normal temperature, resulting in a number of illnesses.
Unique in its focus on adolescents, the trial shows the cardiac myosin inhibitor safely reduces LVOT in the pediatric ...
Alpha Cognition Inc. (ACOG: NASDAQ) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported ...
Twice's agency, JYP Entertainment, recently announced that Dahyun will sit out upcoming performances and Chaeyoung is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results